FDA gives PillCam Colon thumbs down
This article was originally published in The Gray Sheet
Executive Summary
Given Imaging says Feb. 18 it received a "not substantially equivalent" letter from FDA denying its 510(k) application for the PillCam Colon, an ingestible capsule that images the colon. The firm would not disclose details of the letter, but said it is evaluating options to get the device to the U.S. market and is accelerating development of the Colon 2 next-generation capsule. PillCam Colon was approved in Europe in 2006. FDA has cleared PillCam SB 2, for the small bowel, and PillCam ESO 2, for the esophagus. On Feb. 20, Given reported 2007 sales of $112.8 million, a 19% increase over the prior year. The firm's guidance for sales in 2008 is $130 million-$136 million
You may also be interested in...
Given To Launch Next-Gen Colonoscopy PillCam In Europe In November
Given Imaging expects its PillCam COLON 2 endoscopy capsule will overcome many of the limitations identified in a recent clinical trial comparing its first-generation PillCam COLON to standard colonoscopy
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.